IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i22p14845-d969828.html
   My bibliography  Save this article

Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care

Author

Listed:
  • Catherine Laporte

    (Clermont Auvergne Institut Pascal (INP), CNRS, Centre Hospitalo-Universitaire (CHU) Clermont-Ferrand, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Frédéric Fortin

    (Clermont Auvergne Institut Pascal (INP), CNRS, Centre Hospitalo-Universitaire (CHU) Clermont-Ferrand, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Julie Dupouy

    (Unite Mixte de Recherche (UMR) 1295 Inserm, Université Toulouse III, F-31000 Toulouse, France
    Maison de Santé Pluriprofessionelle Universitaire de Pins Justaret, F-31860 Pins Justaret, France)

  • Aurélie Quirin

    (Clermont Auvergne Institut Pascal (INP), CNRS, Centre Hospitalo-Universitaire (CHU) Clermont-Ferrand, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Bruno Pereira

    (Unité de Biostatistiques, Direction de la Recherche Clinique et de l’Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France)

  • Chouki Chenaf

    (CHU Clermont-Ferrand, Service de Pharmacologie Médicale, Centre d’Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Jessica Delorme

    (CHU Clermont-Ferrand, Service de Pharmacologie Médicale, Centre d’Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Christine Maynié-François

    (UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive (LBBE), Équipe Evaluation et Modélisation des Effets Thérapeutiques (EMET), Université Claude Bernard Lyon 1, F-69100 Lyon, France)

  • Cédric Rat

    (Département de Médecine Générale, Université de Nantes-INSERM U1302/CNRS EMR6001-Équipe 2, F-44035 Nantes, France)

  • Jordan Birebent

    (Unite Mixte de Recherche (UMR) 1295 Inserm, Université Toulouse III, F-31000 Toulouse, France
    Maison de Santé Pluriprofessionelle Universitaire de Pins Justaret, F-31860 Pins Justaret, France)

  • Jacques Rambaud

    (Département de Médecine Générale, Université Montpellier, F-34090 Montpellier, France)

  • Christian Duale

    (Unité de Biostatistiques, Direction de la Recherche Clinique et de l’Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France)

  • Nicolas Kerckhove

    (CHU Clermont-Ferrand, Service de Pharmacologie Médicale, Centre d’Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Noémie Delage

    (CHU Clermont-Ferrand, Service de Pharmacologie Médicale, Centre d’Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

  • Nicolas Authier

    (CHU Clermont-Ferrand, Service de Pharmacologie Médicale, Centre d’Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Université Clermont Auvergne, F-63000 Clermont-Ferrand, France)

Abstract

Analgesic opioid (AO) misuse by patients ranges from 0% to 50%. General practitioners are the first prescribers of AO. Our objective was to validate the Prescription Opioid Misuse Index (POMI) in primary care. We conducted a psychometric study in patients with chronic pain who had been taking AOs for at least 3 months and were followed in general practice. Patients responded to the POMI at inclusion and after 2 weeks. The reference used was the DSM-V. Sixty-nine GPs included 160 patients (87 women, 54.4%), mean age 56.4 ± 15.2 years. The total POMI score was 1.50 ± 1.27, and 73/160 (45.6.0%) had a score ≥ 2 (misuse threshold). Internal validity was measured with the Kuder–Richardson coefficient, which was 0.44. Correlations between each item and the total score ranged from 0.06 to 0.35. Test–retest reliability was determined from 145 patients: Lin’s concordance coefficient was 0.57 [0.46, 0.68]. Correlation with the DSM-V (Spearman’s coefficient) was 0.52. The POMI does not have sufficient psychometric properties to be recommended as a tool to identify the misuse of AOs in primary care. This study clearly showed that there is a need to create a monitoring tool specific to primary care.

Suggested Citation

  • Catherine Laporte & Frédéric Fortin & Julie Dupouy & Aurélie Quirin & Bruno Pereira & Chouki Chenaf & Jessica Delorme & Christine Maynié-François & Cédric Rat & Jordan Birebent & Jacques Rambaud & Chr, 2022. "Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care," IJERPH, MDPI, vol. 19(22), pages 1-13, November.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:22:p:14845-:d:969828
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/22/14845/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/22/14845/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:22:p:14845-:d:969828. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.